MDCO News and Press, The Medicines Company From 02/26/19

AES , AMRN , AMT , ANIP , BBY , CHK , CLH , CPB , DF , DNR , DOC , DY , EYE , FTDR , GCP , GTE , HMLP , HPT , HZNP , IONS , LIVN , LOW , LXP , MDCO , MGPI , MIDD , NEWM , NOVT , OCN , ODP , PEG , PGTI , PNM , RDC , SBGI , SHOO , TAST , TJX , UTHR F...

The Medicines Company (NASDAQ:MDCO) announced today that management will present company overviews at the following conferences: 8th Annual SVB Leerink Global Healthcare Conference on Thursday, February 28, 2019 at 9 a.m. EST at the Lotte New York Palace Hotel in New York City The ...

The Medicines Company (NASDAQ:MDCO) will host a conference call and audio webcast on Wednesday, February 27, 2019, at 8:30 a.m. EST to discuss its fourth-quarter and full-year 2018 financial results and operational developments. The conference call may be accessed by telephone as follows...

This article is part of a series that provides an ongoing analysis of the changes made to David Einhorn’s Greenlight Capital 13F portfolio on a quarterly basis. It is based on Einhorn’s regulatory 13F Form filed on 02/14/2019. Please visit our Tracking David Einhorn's Greenlig...

Biotech Pulse Biotech tumbled off a steep ski slope in the last quarter, and at the December low, the Nasdaq Biotechnology Index ( IBB ) had declined -28%, while the S&P Biotech Select Index ( XBI ) a whopping -36%. But it seems biotechs were able to regain their composure at the lows an...

NEW YORK, Jan. 30, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Leidos Holdings, Inc. (NYSE:LDOS), Nomad Foods Limited (NYSE:NOMD), Hu...

Valuing a pharmaceutical company stock like The Medicine Company ( MDCO ) requires knowledge of clinical trial stages, success rates within peer groups, drug substitutes, patent expiration timeframes, and ideally a medical background that allows analysis of the ongoing clinical trials involved...

Merger Monday is alive and well in the healthcare sector with two big acquisitions thus far in 2019 with Bristol-Myers agreeing to buy Celgene Corp. in a deal valued at $74 billion and Eli Lilly & Company agreeing to acquire Loxo Oncology Inc. for roughly $8 billion. Only time will tel...

In late 2017 I published an article based on analyst recommendations and how well those recommendations pan out. The data was based on information compiled by FactSet Research for analyst recommendations as of Dec.31, 2016. The ratings were divided up in quintiles based on the highest percen...

2019 is a momentous year for inclisiran, a first in class therapy with the potential to deliver potent, durable and consistent lowering of LDL-C levels via twice-a-year dosing. With full commercial rights in all geographies, The Medicines Company is well placed to harness the intrinsic...